These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Applicability of non-cholesterol sterols in predicting response in cholesterol metabolism to simvastatin and fluvastatin treatment among hypercholesterolemic men. Nissinen MJ, Miettinen TE, Gylling H, Miettinen TA. Nutr Metab Cardiovasc Dis; 2010 Jun; 20(5):308-16. PubMed ID: 19695854 [Abstract] [Full Text] [Related]
5. Serum noncholesterol sterols in children with heterozygous familial hypercholesterolemia undergoing pravastatin therapy. Hedman M, Miettinen TA, Gylling H, Ketomäki A, Antikainen M. J Pediatr; 2006 Feb; 148(2):241-6. PubMed ID: 16492436 [Abstract] [Full Text] [Related]
9. Synthesis and absorption markers of cholesterol in serum and lipoproteins during a large dose of statin treatment. Miettinen TA, Gylling H. Eur J Clin Invest; 2003 Nov; 33(11):976-82. PubMed ID: 14636301 [Abstract] [Full Text] [Related]
14. Blood glucose and the metabolism of cholesterol in coronary patients with and without simvastatin treatment. Miettinen TA, Gylling H, Subgroup analysis of Scandinavian Simvastatin Survival Study (4S). Clin Chim Acta; 2007 Apr; 379(1-2):53-8. PubMed ID: 17258182 [Abstract] [Full Text] [Related]
15. Red cell and plasma plant sterols are related during consumption of plant stanol and sterol ester spreads in children with hypercholesterolemia. Ketomäki AM, Gylling H, Antikainen M, Siimes MA, Miettinen TA. J Pediatr; 2003 May; 142(5):524-31. PubMed ID: 12756385 [Abstract] [Full Text] [Related]
16. Comparison of rosuvastatin with atorvastatin, simvastatin and pravastatin in achieving cholesterol goals and improving plasma lipids in hypercholesterolaemic patients with or without the metabolic syndrome in the MERCURY I trial. Stender S, Schuster H, Barter P, Watkins C, Kallend D, MERCURY I Study Group. Diabetes Obes Metab; 2005 Jul; 7(4):430-8. PubMed ID: 15955130 [Abstract] [Full Text] [Related]
17. Apolipoprotein modifying effects of statins and fibrate in various age groups of coronary artery disease patients. Sharma R, Mahajan M, Singh B, Bal BS, Kant R. J Indian Med Assoc; 2006 Sep; 104(9):492-4, 496, 498. PubMed ID: 17388006 [Abstract] [Full Text] [Related]